The Inflammatory Microenvironment in Vestibular Schwannoma. Issue 2 (27th February 2020)

• Record Type: Journal Article
• Authors: Hannan, Cathal; Lewis, Daniel; O'Leary, Claire; Donofrio, Carmine A; Evans, Daffyd Gareth; Roncaroli, Federico; Brough, David; King, Andrew Thomas; Coope, David; Pathmanaban, Omar Nathan
• Is Part Of: Neuro-oncology advances. Volume 2:Issue 2(2020)
• Publication Date: 2020-02-27
• Subjects: Vestibular Schwannoma -- Neurofibromatosis Type 2 -- Inflammation -- Macrophages -- Biomarkers; 616.99481
• DOI: 10.1093/noajnl/vdaa023
• Languages: English
• ISSNs: 2632-2498

Abstract

Abstract: Vestibular schwannomas are tumors arising from the vestibulo-cochlear nerve at the cerebello-pontine angle. Their proximity to eloquent brainstem structures means that the pathology itself and the treatment thereof can be associated with significant morbidity. The vast majority of these tumors are sporadic, with the remainder arising as a result of the genetic syndrome Neurofibromatosis Type 2 or, more rarely, LZTR1- related schwannomatosis. The natural history of these tumors is extremely variable, with some tumors not displaying any evidence of growth, others demonstrating early, persistent growth and a small number growing following an extended period of indolence. Emerging evidence now suggests that far from representing Schwann cell proliferation only, the tumor microenvironment is complex, with inflammation proposed to play a key role in their growth. In this review, we provide an overview of this new evidence, including the role played by immune cell infiltration, the underlying molecular pathways involved and biomarkers for detecting this inflammation in vivo . Given the limitations of current treatments, there is a pressing need for novel therapies to aid in the management of this condition, and we conclude by proposing areas for future research, that could lead to the development of therapies targeted towards inflammation in vestibular schwannoma.